Results of a Randomised Controlled Trial Comparing Intravesical Chemohyperthermia with Mitomycin C Versus Bacillus Calmette-Guérin for Adjuvant Treatment of Patients with Intermediate- and High-risk Non–Muscle-invasive Bladder Cancer-Reference-Cited by-同舟云学术

Results of a Randomised Controlled Trial Comparing Intravesical Chemohyperthermia with Mitomycin C Versus Bacillus Calmette-Guérin for Adjuvant Treatment of Patients with Intermediate- and High-risk Non–Muscle-invasive Bladder Cancer

Published:2016-06 Issue:6 Volume:69 Page:1046-1052
ISSN:0302-2838
Container-title:European Urology
language:en
Short-container-title:European Urology

Author:

Arends Tom J.H.,Nativ Ofer,Maffezzini Massimo,de Cobelli Ottavio,Canepa Giorgio,Verweij Fabrizio,Moskovitz Boaz,van der Heijden Antoine G.,Witjes J. Alfred

Publisher

Elsevier BV

Subject

Urology

Reference18 articles.

1. An individual patient data meta-analysis of the long-term outcome of randomised studies comparing intravesical mitomycin C versus bacillus Calmette-Guerin for non-muscle-invasive bladder cancer;Malmstrom;Eur Urol,2009

2. Multicentric study comparing intravesical chemotherapy alone and with local microwave hyperthermia for prophylaxis of recurrence of superficial transitional cell carcinoma;Colombo;J Clin Oncol,2003

3. Long-term outcomes of a randomized controlled trial comparing thermochemotherapy with mitomycin-C alone as adjuvant treatment for non-muscle-invasive bladder cancer (NMIBC);Colombo;BJU Int,2011

4. The role of a combined regimen with intrave sical chemotherapy and hyperthermia in the management of non-muscle-invasive bladder cancer: a systematic review;Lammers;Eur Urol,2011

5. ICH harmonised tripartite guideline: guideline for good clinical practice;J Postgrad Med,2001

Cited by 192 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparing efficacy and safety of in-house gemcitabine to mitomycin for bladder instillation in intermediate-risk NMIBC;The French Journal of Urology;2024-12

2. Efficacy and tolerance of hyperthermic intravesical chemotherapy (HIVEC) according to the number of instillations administered;World Journal of Urology;2024-09-11

3. Clinical and molecular response to alpha1‐oleate treatment in patients with bladder cancer;Cancer Medicine;2024-09

4. Treatment Strategies for BCG Unresponsive Non-muscle Invasive Bladder Cancer;annals of urologic oncology;2024-08-29

5. European Association of Urology Guidelines on Non–muscle-invasive Bladder Cancer (TaT1 and Carcinoma In Situ)—A Summary of the 2024 Guidelines Update;European Urology;2024-08